Xencor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.About XNCR
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
CEOBassil I. Dahiyat
CEOBassil I. Dahiyat
Employees250
Employees250
HeadquartersPasadena, California
HeadquartersPasadena, California
Founded1997
Founded1997
Employees250
Employees250
XNCR Key Statistics
Market cap1.29B
Market cap1.29B
Price-Earnings ratio-10.22
Price-Earnings ratio-10.22
Dividend yield—
Dividend yield—
Average volume668.71K
Average volume668.71K
High today$18.68
High today$18.68
Low today$17.02
Low today$17.02
Open price$17.50
Open price$17.50
Volume932.86K
Volume932.86K
52 Week high$26.59
52 Week high$26.59
52 Week low$6.92
52 Week low$6.92
Stock Snapshot
With a market cap of 1.29B, Xencor(XNCR) trades at $18.14. The stock has a price-to-earnings ratio of -10.22.
During the trading session on 2025-12-05, Xencor(XNCR) shares reached a daily high of $18.68 and a low of $17.02. At a current price of $18.14, the stock is +6.6% higher than the low and still -2.9% under the high.
Trading volume for Xencor(XNCR) stock has reached 932.86K, versus its average volume of 668.71K.
Over the past 52 weeks, Xencor(XNCR) stock has traded between a high of $26.59 and a low of $6.92.
Over the past 52 weeks, Xencor(XNCR) stock has traded between a high of $26.59 and a low of $6.92.
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%
People also own
Based on the portfolios of people who own XNCR. This list is generated using Robinhood data, and it’s not a recommendation.